Pacific Biosciences Of California Net Profit Margin 2010-2023 | PACB
Pacific Biosciences Of California net profit margin from 2010 to 2023. Net profit margin can be defined as net Income as a portion of total sales revenue.
| Pacific Biosciences Of California Net Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Net Income | Net Margin |
| 2023-12-31 | $0.20B | $-0.31B | -152.74% |
| 2023-09-30 | $0.17B | $-0.31B | -181.76% |
| 2023-06-30 | $0.15B | $-0.32B | -218.49% |
| 2023-03-31 | $0.13B | $-0.32B | -240.60% |
| 2022-12-31 | $0.13B | $-0.31B | -246.46% |
| 2022-09-30 | $0.14B | $-0.30B | -219.12% |
| 2022-06-30 | $0.14B | $-0.20B | -146.76% |
| 2022-03-31 | $0.14B | $-0.17B | -128.89% |
| 2021-12-31 | $0.13B | $-0.18B | -137.40% |
| 2021-09-30 | $0.12B | $-0.04B | -29.51% |
| 2021-06-30 | $0.11B | $-0.08B | -72.64% |
| 2021-03-31 | $0.09B | $-0.06B | -64.13% |
| 2020-12-31 | $0.08B | $0.03B | 36.71% |
| 2020-09-30 | $0.08B | $-0.05B | -57.50% |
| 2020-06-30 | $0.08B | $-0.05B | -61.45% |
| 2020-03-31 | $0.09B | $-0.05B | -58.24% |
| 2019-12-31 | $0.09B | $-0.08B | -92.31% |
| 2019-09-30 | $0.08B | $-0.12B | -138.55% |
| 2019-06-30 | $0.08B | $-0.11B | -140.51% |
| 2019-03-31 | $0.08B | $-0.11B | -143.42% |
| 2018-12-31 | $0.08B | $-0.10B | -130.38% |
| 2018-09-30 | $0.08B | $-0.09B | -110.71% |
| 2018-06-30 | $0.09B | $-0.09B | -100.00% |
| 2018-03-31 | $0.09B | $-0.09B | -105.68% |
| 2017-12-31 | $0.09B | $-0.09B | -98.94% |
| 2017-09-30 | $0.10B | $-0.09B | -95.79% |
| 2017-06-30 | $0.10B | $-0.09B | -89.58% |
| 2017-03-31 | $0.10B | $-0.08B | -80.41% |
| 2016-12-31 | $0.09B | $-0.07B | -80.22% |
| 2016-09-30 | $0.10B | $-0.06B | -54.46% |
| 2016-06-30 | $0.09B | $-0.04B | -40.00% |
| 2016-03-31 | $0.09B | $-0.03B | -31.91% |
| 2015-12-31 | $0.09B | $-0.03B | -33.33% |
| 2015-09-30 | $0.07B | $-0.05B | -66.22% |
| 2015-06-30 | $0.08B | $-0.06B | -74.07% |
| 2015-03-31 | $0.07B | $-0.07B | -100.00% |
| 2014-12-31 | $0.06B | $-0.07B | -108.20% |
| 2014-09-30 | $0.05B | $-0.06B | -120.75% |
| 2014-06-30 | $0.04B | $-0.08B | -192.31% |
| 2014-03-31 | $0.03B | $-0.08B | -223.53% |
| 2013-12-31 | $0.03B | $-0.08B | -278.57% |
| 2013-09-30 | $0.03B | $-0.08B | -332.00% |
| 2013-06-30 | $0.02B | $-0.09B | -409.52% |
| 2013-03-31 | $0.02B | $-0.09B | -400.00% |
| 2012-12-31 | $0.03B | $-0.10B | -365.38% |
| 2012-09-30 | $0.03B | $-0.10B | -300.00% |
| 2012-06-30 | $0.04B | $-0.10B | -255.00% |
| 2012-03-31 | $0.04B | $-0.10B | -231.82% |
| 2011-12-31 | $0.03B | $-0.11B | -320.59% |
| 2011-09-30 | $0.02B | $-0.12B | -554.55% |
| 2011-06-30 | $0.01B | $-0.13B | -1218.18% |
| 2011-03-31 | $0.00B | $-0.15B | -14500.00% |
| 2010-12-31 | $0.00B | $-0.14B | -7000.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.394B | $0.201B |
| Pacific Biosciences of California Inc., popularly known as PacBio, develops, manufactures and markets sequencing systems, which help in studying synthesis, composition, structure and regulation of deoxyribonucleic acid, popularly known as DNA. PacBio's products are based on Single Molecule, Real-Time (SMRT) technology. SMRT generates long reads that help in assembling a whole human genome from scratch, without using an existing reference genome as a template. This process is known as de novo assembly. To observe DNA replication process smoothly, PacBio offers the SMRT Cell, Phospholinked nucleotides and The PacBio RS II System. The PacBio RS II System includes the PacBio RS II instrument, consumables and software. PacBio launched its new Sequel system based on SMRT technology. PacBio deferred the gain from the Reverse Termination Fee from Illumina until the date when the associated contingency was resolved. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $219.329B | 26.67 |
| Intuitive Surgical (ISRG) | United States | $133.752B | 80.57 |
| DexCom (DXCM) | United States | $53.067B | 88.74 |
| Edwards Lifesciences (EW) | United States | $52.819B | 34.96 |
| IQVIA Holdings (IQV) | United States | $43.310B | 25.69 |
| IDEXX Laboratories (IDXX) | United States | $41.012B | 49.04 |
| Alcon (ALC) | Switzerland | $39.823B | 29.37 |
| STERIS (STE) | Ireland | $20.355B | 24.09 |
| Waters (WAT) | United States | $18.582B | 26.66 |
| Hologic (HOLX) | United States | $18.119B | 20.00 |
| SONOVA HOLDING (SONVY) | Switzerland | $16.651B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $12.605B | 15.56 |
| ShockWave Medical (SWAV) | United States | $12.286B | 84.89 |
| Sysmex ADR (SSMXY) | Japan | $10.120B | 31.74 |
| Teleflex (TFX) | United States | $9.944B | 15.61 |
| Penumbra (PEN) | United States | $7.961B | 98.42 |
| Masimo (MASI) | United States | $7.246B | 40.64 |
| Globus Medical (GMED) | United States | $6.941B | 22.00 |
| Glaukos (GKOS) | United States | $5.074B | 0.00 |
| Integer Holdings (ITGR) | United States | $3.950B | 25.25 |
| LivaNova (LIVN) | United Kingdom | $2.969B | 19.58 |
| TransMedics (TMDX) | United States | $2.964B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $2.763B | 0.00 |
| Elekta AB (EKTAY) | Sweden | $2.704B | 18.55 |
| Nihon Kohden (NHNKY) | Japan | $2.379B | 20.12 |
| Integra LifeSciences Holdings (IART) | United States | $2.309B | 9.48 |
| Tandem Diabetes Care (TNDM) | United States | $2.258B | 0.00 |
| Inari Medical (NARI) | United States | $2.151B | 371.10 |
| RxSight (RXST) | United States | $2.031B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $1.784B | 0.00 |
| Veracyte (VCYT) | United States | $1.489B | 0.00 |
| OPKO Health (OPK) | United States | $0.871B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.867B | 16.03 |
| Artivion (AORT) | United States | $0.856B | 98.95 |
| Paragon 28 (FNA) | United States | $0.833B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.729B | 0.00 |
| Silk Road Medical (SILK) | United States | $0.692B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.671B | 0.00 |
| SiBone (SIBN) | United States | $0.627B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.575B | 19.53 |
| IRadimed (IRMD) | United States | $0.531B | 30.81 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.495B | 0.00 |
| Nevro (NVRO) | United States | $0.469B | 0.00 |
| NeuroPace (NPCE) | United States | $0.402B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $0.379B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.346B | 11.66 |
| CVRx (CVRX) | United States | $0.309B | 0.00 |
| AxoGen (AXGN) | United States | $0.305B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.279B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.263B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.242B | 0.00 |
| Accuray (ARAY) | United States | $0.220B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.190B | 10.26 |
| Atossa Genetics (ATOS) | United States | $0.187B | 0.00 |
| 908 Devices (MASS) | United States | $0.183B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.174B | 0.00 |
| Inogen (INGN) | United States | $0.162B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.149B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.142B | 0.00 |
| Neuronetics (STIM) | United States | $0.116B | 0.00 |
| Yubo Biotech (YBGJ) | China | $0.112B | 0.00 |
| Envoy Medical (COCH) | United States | $0.101B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.098B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.086B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.073B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.072B | 0.00 |
| SEP Acquisition (SEPA) | United States | $0.059B | 0.00 |
| Hyperfine (HYPR) | United States | $0.059B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.056B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.056B | 113.33 |
| Vasomedical (VASO) | United States | $0.054B | 9.73 |
| Vicarious Surgical (RBOT) | United States | $0.050B | 0.00 |
| InspireMD (NSPR) | Israel | $0.046B | 0.00 |
| DarioHealth (DRIO) | United States | $0.043B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.042B | 0.00 |
| ReWalk Robotics (LFWD) | Israel | $0.042B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.039B | 0.00 |
| LENSAR (LNSR) | United States | $0.036B | 0.00 |
| Pixie Dust Technologies (PXDT) | Japan | $0.036B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.035B | 0.00 |
| Precision Optics (POCI) | United States | $0.034B | 0.00 |
| Spectral AI (MDAI) | United States | $0.032B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.023B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.021B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.021B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.019B | 0.00 |
| PAVmed (PAVM) | United States | $0.017B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.017B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.015B | 0.00 |
| NexGel (NXGL) | United States | $0.014B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.013B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.013B | 0.00 |
| Avinger (AVGR) | United States | $0.006B | 0.00 |
| Venus Concept (VERO) | Canada | $0.005B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Tenon Medical (TNON) | United States | $0.003B | 0.00 |
| Dynatronics (DYNT) | United States | $0.003B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.001B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |